↓ Skip to main content

American Association for Cancer Research

Gilteritinib Inhibits Glutamine Uptake and Utilization in FLT3-ITD–Positive AML

Overview of attention for article published in Molecular Cancer Therapeutics, September 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter
16 X users

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
22 Mendeley